Activation of CPP32-like protease in tumor necrosis factor-induced apoptosis is dependent on mitochondrial function

Journal of Clinical Investigation

Volumn 99, Issue 7, 1997, Pages 1751-1758

  Higuchi, Masahiro ^a   Aggarwal, Bharat B ^b   Yeh, Edward T H ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

apoptosis; CPP32; mitochondria; staurosporine; tumor necrosis factor

Indexed keywords

ETHIDIUM BROMIDE; PROTEINASE; STAUROSPORINE; TUMOR NECROSIS FACTOR;

APOPTOSIS; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL FUNCTION; COMPLEX FORMATION; CYTOTOXICITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MEDIATOR RELEASE; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; RESPIRATORY CHAIN;

EID: 0030997261     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119339     Document Type: Article

References (46)

1. Carswell, E.A., L.J. Old, R.L. Kassel, S. Green, N. Flore, and B. Williamson. 1975. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA. 72:3666-3670.
2. Matthews, N. 1983. Anti-tumor cytotoxin produced by human monocytes: studies on its mode of action. Br. J. Cancer. 48:405-410.
3. Schulze-Osthof, K., A.C. Bakker, B. Vanhaesebroeck, R. Beyaert, W.A. Jacob, and W. Fiers. 1992. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. J. Biol. Chem. 267:5317-5323.
4. 2 activation caused by tumor necrosis factor. J. Immunother. 2:41-19.
5. Schulze-Osthoff, K., R. Beyaert, V. Vandevoorde, G. Haegeman, and W. Fiers. 1993. Depletion of mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO (Eur. Mol. Biol. Organ.) J. 12: 3095-3104.
6. Kobayashi, Y., J. Sawada, and T. Osawa. 1979. Activation of membrane phospholipase A by guinea pig lymphotoxin (GLT). J. Immunol. 122:791-794.
7. Neale, M.L., R.A. Fiera, and D. Matthews. 1988. Involvement of phospholipase A2 activation in tumor cell killing by tumor necrosis factor. Immunology. 64:81-85.
8. Hayakawa, M., N. Ishida, K. Takeuchi, S. Shibamoto, T. Hori, N. Oku, F. Ito, and M. Tsujimoto. 1993. Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor. J. Biol. Chem. 268: 11290-11295.
9. Oheid, L.M., C.M. Linardic, L.A. Karolak, and Y.A. Hannun. 1993. Programmed cell death induced by ceramide. Science (Wash. DC). 259:1769-1772.
10. Kolesnick, R., and D.W. Golde. 1994. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell. 77:325-340.
11. Takeda, Y., S. Shimada, M. Sugimoto, H.J. Woo, M. Higuchi, and T. Osawa. 1985. Purification and characterization of a cytotoxic factor produced by a mouse macrophage hybridoma. Cell. Immunol. 96:277-283.
12. Ruggiero, V., S.E. Johnson, and C. Baglion. 1987. Protection from tumor necrosis factor cytotoxicity by protease inhibitors. Cell. Immunol. 107:317-325.
13. Suffys, P., R. Beyaert, F. Van Roy, and W. Fiers. 1988. Involvement of a serine protease in tumor-necrosis-factor-mediated cytotoxicity. FEBS Lett. 178: 257-265.
14. Miura, M., R.M. Friedlander, and J. Yuan. 1995. Tumor necrosis factor-induced apoptosis is mediated by CrmA-sensitive cell death pathway. Proc. Natl. Acad. Sci. USA. 92:8318-8322.
15. Williams, M.S., and P.A. Henkart. 1994. Apoptotic cell death induced by intracellular proteolysis. J. Immunol. 153:4247-1255.
16. Nicholson, D.W., A. Ali, N.A. Thornberry, J.P. Vailancourt, C.K. Ding, M. Gallant, Y. Gereau, P.R. Griffin, M. Labelle, Y.A. Lazebnik, et al. 1995. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature (Lond.). 376:37-43.
17. Schlegel, J., I. Peters, S. Orrenius, D.K. Miller, N.A. Thornberry, T.-T. Yamin, and D.W. Nicholson. 1996. CPP32/Apopain is a key interleukin 1b converting enzyme-like protease involved in Fas-mediated apoptosis. J. Biol. Chem. 271:1841-1844.
18. Jacobson, M.D., M. Weil, and M.C. Raff. 1996. Role of Ced-3/ICE-family proteases in staurosporine-induced programmed cell death. J. Cell Biol. 133: 1041-1051.
19. Fujita, E., T. Mukasa, T. Tsukahara, K. Arahata, S. Omura, and T. Momoi. 1996. Enhancement of CPP32-like activity in the TNF-treated U937 cells by the proteasome inhibitors. Biochem. Biophys. Res. Commun. 224:74-79.
20. Mizuo, M., A.M. Chinnaiyan, F.C. Kischkel, K. O'Rourke, A. Shevchenko, J. Ni, C. Scaffidi, J.D. Bretz, M. Zhang, R. Gentz, et al. 1996. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is required to CD95 (Fas/APO-1) death-inducing signaling complex. Cell. 85:817-827.
21. Boldin, M.P., T.M. Goncharov, Y.V. Goltsev, and D. Wallach. 1996. Involvement of MACH, a novel MORT1/FADD-interacting protease. in Fas/ APO-1 and TNF receptor-induced cell death. Cell. 85:803-815.
22. Lennon, S.V., S.J. Martin, and T.G. Cotter. 1991. Dose-dependent induction of apoptosis in human tumor cell lines by widely diverging stimuli. Cell Prolif. 24:203-214.
23. Wong, G.H.W., J.H. Elwell, L.W. Oberly, and D.V. Goeddel. 1989. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicily of tumor necrosis factor. Cell. 58:923-931.
24. Hennet, T., C. Richte, and E. Peterhans. 1992. Tumor necrosis factor-α induced superoxide anion generation in mitochondria of L929 cells. Biochem. J. 289:587-592.
25. Goossens, V., J. Grooten, K.D. Vos, and W. Fiers. 1995. Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc. Natl. Acad. Sci. USA. 92:8115-8119.
26. 2+: their relationship to apoptosis and oncogenesis. FEBS Lett. 325:104-107.
27. Zamzami, N., A.S. Susin, P. Merchetti, T. Hirsch, I. Gómez-Monterrey. M. Castedo, and G. Kromer. 1996 Mitochondrial control of nuclear apoptosis. J. Exp. Med. 183:1533-1544.
28. Hennet, T., G. Bertoni, C. Richter, and E. Peterhans. 1993. Expression of Bcl-2 protein enhances the survival of mouse fibrosarcoid cells in tumor necrosis factor-mediated cytotoxicity. Cancer Res. 53:1456-1460.
29. Liu, X., C.N. Kim, J. Yang, R. Jemmerson, and X. Wang. 1996. Induction of apoptotic program in cell-free extracts: requirement of dATP and cytochrome c. Cell. 86:147-157.
30. Vanhaesebroeck, B., S.V. Bladel, A. Lenaerts, P. Suffys, R. Beyaert, R. Lucas, F.V. Roy, and W. Fiers. 1991. Two discrete types of tumor necrosis factor-resistant cells derived from the small cell line. Cancer Res. 51:2369-2477.
31. Schulze-Osthoff, K., P.H. Krammer, and W. Droge. 1994. Divergent signalling via APO-1/Fas and TNF receptor, two homologous molecules involved in physiological cell death. EMBO (Eur. Mol. Biol. Organ.) J. 13:4587-4596.
32. King, M.P., and G. Attardi. 1989. Human cells lacking mtDNA: replication with exogenous mitochondria by complementation. Nature (Lond.). 246: 500-503.
33. Lys mutation causing myoclonic epilepsy and ragged red fibers. Am. J. Hum. Genet. 54:966-974.
34. Higuchi, M., S. Singh, and B.B. Aggarwal. 1995. Characterization of the apoptotic effects of human tumor necrosis factor: development of highly rapid and specific bioassay for human tumor necrosis factor and lymphotoxin using human target cells. J. Immunol. Mathods. 178:173-181.
35. Kull, F.C., and P. Cuatrecasas. 1981. Possible requirement of internalization in the mechanism of in vitro cytotoxicity in tumor necrosis serum. Cancer Res. 41:4885-4890.
36. Baehner, R.L., and D.G. Nathan. 1968. Quantitative nitroblue tetrazolium test in chronic granulomatous disease. N. Engl. J. Med. 278:971-976.
37. Granger, D.L., and A.L. Lehninger. 1982. Sites of inhibition of mitochondrial electron transport in macrophage-injured neoplastic cells. J. Cell Biol. 95:527-535.
38. Enari, M., R.V. Talanian, W.W. Wong, and S. Nagata. 1996. Sequential activation of ICE-like and CPP-32-like proteases during Fas-mediated apoptosis. Nature (Lond.). 380:723-726.
39. Higuchi, M., and B.B. Aggarwal. 1994. Differential role of the p60 and p80 forms of the TNF receptor in TNF induced cytotoxicity. DNA fragmentation and differentiation. J. Immunol. 152:4017-4025.
40. Desjardins, P., E. Frost, and R. Morals. 1985. Ethidium bromide-induced loss of mitochondrial DNA from primary chicken embryo fibroblasts. Mol. Cell. Biol. 5:1163-1169.
41. O'Donnell, V.B., S. Spycher, and A. Azzi. 1995. Involvement of oxidants and oxidant-generating enzyme(s) in tumor-necrosis-factor-a-mediated apoptosis: role for lipoxygenase pathway but not mitochondrial respiratory chain. Biochem. J. 310:133-141.
42. Jacobson, M.D., J.F. Burne, M.P. King, T. Miyashita, J.C. Reed, and M.C. Raff. 1993. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature (Lond.). 361:365-369.
43. Jacobson, M.D., and M.C. Raff. 1995. Programmed cell death and Bcl-2 protection in very low oxygen. Nature (Lond.). 374:814-816.
44. Higuchi, M., S. Singh, H. Chan, and B.B. Aggarwal. 1995. Protease inhibitors differentially regulate tumor necrosis factor-induced apoptosis, nuclear factor-κB activation, cytotoxicity, and differentiation. Blood. 86:2248-2256.
45. Chinnaiyan, A.M., K. Orth, K. O'Rourke, H. Duan, G.G. Poirier, and V.M. Dixit. 1996. Molecular ordering of the cell death pathway. J. Biol. Chem. 271:4573-4576.
46. Zamzami, N., S.A. Susin, P. Marchetti, T. Hirsch. I. Gómez-Monterrey, M. Castedo, and G. Kroemer. 1996. Mitochondrial control of nuclear apoptosis. J. Exp. Med. 183:1533-1544.